statistiche ricercatore

Continente	#
NA - Nord America	342
AS - Asia	332
EU - Europa	200
Continente sconosciuto - Info sul continente non disponibili	30
SA - Sud America	29
AF - Africa	8
Totale	941

Nazione	#
US - Stati Uniti d'America	322
SG - Singapore	131
IT - Italia	78
VN - Vietnam	65
HK - Hong Kong	52
CN - Cina	27
BR - Brasile	23
DE - Germania	23
IE - Irlanda	22
RU - Federazione Russa	21
KR - Corea	14
CA - Canada	12
GB - Regno Unito	12
FI - Finlandia	11
FR - Francia	5
JP - Giappone	5
AT - Austria	4
BD - Bangladesh	4
IN - India	4
LT - Lituania	4
NL - Olanda	4
PH - Filippine	4
SE - Svezia	4
TH - Thailandia	4
ES - Italia	3
GT - Guatemala	3
IQ - Iraq	3
PK - Pakistan	3
PL - Polonia	3
TR - Turchia	3
AR - Argentina	2
AZ - Azerbaigian	2
CZ - Repubblica Ceca	2
EG - Egitto	2
JO - Giordania	2
LB - Libano	2
SC - Seychelles	2
ZA - Sudafrica	2
BE - Belgio	1
BO - Bolivia	1
BS - Bahamas	1
CH - Svizzera	1
CL - Cile	1
CO - Colombia	1
CW - ???statistics.table.value.countryCode.CW???	1
EE - Estonia	1
ET - Etiopia	1
EU - Europa	1
HN - Honduras	1
ID - Indonesia	1
LA - Repubblica Popolare Democratica del Laos	1
LC - Santa Lucia	1
MX - Messico	1
MY - Malesia	1
NG - Nigeria	1
OM - Oman	1
PE - Perù	1
PS - Palestinian Territory	1
PT - Portogallo	1
QA - Qatar	1
SA - Arabia Saudita	1
TT - Trinidad e Tobago	1
Totale	913

Nome	#
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice	187
ARPIR: automatic RNA-Seq pipelines with interactive report	149
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML	116
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML	116
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis	111
SiCoDEA: A Simple, Fast and Complete App for Analyzing the Effect of Individual Drugs and Their Combinations	86
NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential	78
Omacetaxine mepessucinate plus venetoclax show strong synergistic anti-leukemic activity in nucleophosmin (NPM1)-mutated AML patient-derived xenograft (PDX) models to support a phase 1 clinical trial	38
ISOCITRATE DEHYDROGENASES AML-ASSOCIATED POINT MUTATIONS DRIVE A BLOCK OF DIFFERENTIATION IN HUMAN NORMAL CD34+HEMATOPOIETIC CELLS THAT IS RELEASED BY SPECIFIC INHIBITORS	31
Tuned IL3-Zetakine Coupled to a CD33 Costimulatory Receptor As a Dual CAR for Safer and Selective Targeting of Acute Myeloid Leukemia	29
Totale	941

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	13	0	0	0	0	2	0	0	5	0	1	3	2
2022/2023	67	2	10	0	6	2	4	4	2	23	7	6	1
2023/2024	83	2	8	6	4	0	3	21	2	9	6	6	16
2024/2025	210	9	17	4	14	17	16	30	38	24	7	22	12
2025/2026	401	26	29	11	42	46	37	57	21	77	37	11	7
2026/2027	105	18	20	30	37	0	0	0	0	0	0	0	0
Totale													941

IRIS - Res&Arch Institutional Research Information System - Research & Archive